Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New survey aims to map haemophilia care across Asia-Pacific

NCT ID NCT07163260

ENROLLING_BY_INVITATION Knowledge-focused Sponsor: Novo Nordisk A/S Source: ClinicalTrials.gov ↗

First seen Oct 31, 2025 · Last updated Apr 30, 2026 · Updated 28 times

Summary

This study collects information from doctors and patient groups about haemophilia in Asia-Pacific countries. It aims to learn how many people have the condition, how often new cases occur, and what care is currently available. No treatments or medications are given—this is a survey-only study.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HAEMOPHILIA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Novo Nordisk Investigational Site

    Bangalore, Karnataka, 560 066, India

  • Novo Nordisk Investigational Site

    Kuala Lumpur, 50470, Malaysia

  • Novo Nordisk Investigational Site

    Seoul, South Korea

  • Novo Nordisk Investigational Site

    Bangkok, 10500, Thailand

Conditions

Explore the condition pages connected to this study.